Cargando…

Advanced Research on Immune Checkpoint Inhibitor Therapy

Detalles Bibliográficos
Autores principales: Imai, Hisao, Kaira, Kyoichi, Kagamu, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501691/
https://www.ncbi.nlm.nih.gov/pubmed/36143036
http://dx.doi.org/10.3390/jcm11185392
_version_ 1784795535928983552
author Imai, Hisao
Kaira, Kyoichi
Kagamu, Hiroshi
author_facet Imai, Hisao
Kaira, Kyoichi
Kagamu, Hiroshi
author_sort Imai, Hisao
collection PubMed
description
format Online
Article
Text
id pubmed-9501691
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-95016912022-09-24 Advanced Research on Immune Checkpoint Inhibitor Therapy Imai, Hisao Kaira, Kyoichi Kagamu, Hiroshi J Clin Med Editorial MDPI 2022-09-14 /pmc/articles/PMC9501691/ /pubmed/36143036 http://dx.doi.org/10.3390/jcm11185392 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Editorial
Imai, Hisao
Kaira, Kyoichi
Kagamu, Hiroshi
Advanced Research on Immune Checkpoint Inhibitor Therapy
title Advanced Research on Immune Checkpoint Inhibitor Therapy
title_full Advanced Research on Immune Checkpoint Inhibitor Therapy
title_fullStr Advanced Research on Immune Checkpoint Inhibitor Therapy
title_full_unstemmed Advanced Research on Immune Checkpoint Inhibitor Therapy
title_short Advanced Research on Immune Checkpoint Inhibitor Therapy
title_sort advanced research on immune checkpoint inhibitor therapy
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501691/
https://www.ncbi.nlm.nih.gov/pubmed/36143036
http://dx.doi.org/10.3390/jcm11185392
work_keys_str_mv AT imaihisao advancedresearchonimmunecheckpointinhibitortherapy
AT kairakyoichi advancedresearchonimmunecheckpointinhibitortherapy
AT kagamuhiroshi advancedresearchonimmunecheckpointinhibitortherapy